Viking's VK2735 shows promise in obesity treatment but faces tolerability concerns. Discover market impact, buyout potential, ...

COMMENT: The monthly cost of a private prescription exceeding £300 from next month is worrying news for the half a million ...

Early trials of the drug, retatrutide, have already shown it can help people shed a quarter of their body weight in under a ...

From 1 September, the list price for the most popular and effective weight loss injection (Mounjaro) in the UK will rise by ...

Welcome to the Money blog, Sky News' consumer and personal finance hub. Today: we take an overview of the mortgage market and ...

BRITAIN has gone fat jab crazy — with sales of Wegovy soaring by more than 2,000 per cent in the past month. Dieters are ...

Criminals were caught trying to import the likes of Wegovy and Mounjaro in 'large-scale' smuggling operations.

Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...

A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...